<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45297">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02002026</url>
  </required_header>
  <id_info>
    <org_study_id>U1111-1150-4666</org_study_id>
    <nct_id>NCT02002026</nct_id>
  </id_info>
  <brief_title>Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa</brief_title>
  <official_title>Uterine Artery Ligation to Minimize Blood Loss in Patients With Central Placenta Previa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia Maternity University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia Maternity University Hospital</source>
  <oversight_info>
    <authority>Egypt: Ministry of Higher Education</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will address the effect of uterine artery ligation during Cesarean section in
      cases with placenta previa to decrease blood loss.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Study will address the effect of uterine artery ligation prior to fetal delivery during
      Cesarean section in cases with central placenta previa to guard against postpartum
      hemorrhage and to minimize blood loss.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Changes in hemoglobin level</measure>
    <time_frame>hemoglobin level will be done baseline and will be repeated 24 hours after delivery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Changes in hemoglobin level before and after CS will reflect the amount of blood loss during operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of uterine contractility.</measure>
    <time_frame>During CS and within 3 hours after CS</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Placenta Previa Without Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Ligation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Uterine artery ligation will be done for patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Conventional CS</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Uterine artery ligation</intervention_name>
    <description>Uterine artery ligation during cesarean section before delivery of the baby</description>
    <arm_group_label>Ligation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of
             the internal os at ultrasound

          -  Symptomatic Placenta previa with at least one episode of bleeding

          -  Estimated gestational age within 28 to 40 weeks

          -  Maternal age &gt; 18 years

          -  Informed consent

          -  Social affiliation

        Exclusion Criteria:

          -  Premature rupture of membranes

          -  Severe bleeding.

          -  Abnormal fetal heart rates.

          -  Pre-eclampsia, chorioamnionitis, severe chronic renal disease.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmad S Sameer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minia Maternity University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmad S Sanad, MD</last_name>
    <phone>+201000222994</phone>
    <email>asasanad@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Minia Maternity University Hospital</name>
      <address>
        <city>Minia</city>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haitham A Bahaa, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ahmad S Sanad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 8, 2013</lastchanged_date>
  <firstreceived_date>November 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia Maternity University Hospital</investigator_affiliation>
    <investigator_full_name>Ahmad Sameer Sanad</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>placenta previa, uterine artery ligation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Placenta Previa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
